APA (7th ed.) Citation

Mullins, E. S., Stasyshyn, O., Alvarez‐Román, M. T., Osman, D., Liesner, R., Engl, W., . . . Abbuehl, B. E. (2017). Extended half‐life pegylated, full‐length recombinant factor VIII for prophylaxis in children with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia, 23(2), 238-246. https://doi.org/10.1111/hae.13119

Chicago Style (17th ed.) Citation

Mullins, E. S., O. Stasyshyn, M. T. Alvarez‐Román, D. Osman, R. Liesner, W. Engl, M. Sharkhawy, and B. E. Abbuehl. "Extended Half‐life Pegylated, Full‐length Recombinant Factor VIII for Prophylaxis in Children with Severe Haemophilia A." Haemophilia : The Official Journal of the World Federation of Hemophilia 23, no. 2 (2017): 238-246. https://doi.org/10.1111/hae.13119.

MLA (9th ed.) Citation

Mullins, E. S., et al. "Extended Half‐life Pegylated, Full‐length Recombinant Factor VIII for Prophylaxis in Children with Severe Haemophilia A." Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 23, no. 2, 2017, pp. 238-246, https://doi.org/10.1111/hae.13119.